Page last updated: 2024-09-04

ezetimibe and Intracranial Hemorrhages

ezetimibe has been researched along with Intracranial Hemorrhages in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Amarenco, P; Bruckert, E; Charles, H; Giroud, M; Kim, JS; Labreuche, J; Lavallée, PC; Lee, BC; Mahagne, MH; Meseguer, E; Nighoghossian, N; Steg, PG; Vicaut, É	1

Trials

1 trial(s) available for ezetimibe and Intracranial Hemorrhages

Article	Year
Intracranial Hemorrhage in the TST Trial. Stroke, 2022, Volume: 53, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Coronary Artery Disease; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Intracranial Arteriosclerosis; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Secondary Prevention; Young Adult	2022

Article

Year

Intracranial Hemorrhage in the TST Trial.

Stroke, 2022, Volume: 53, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Coronary Artery Disease; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Intracranial Arteriosclerosis; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Secondary Prevention; Young Adult

2022